Literature DB >> 467924

Effect of vagotomy in Zollinger-Ellison syndrome.

C T Richardson, M Feldman, R N McClelland, R M Dickerman, D Kumpuris, J S Fordtran.   

Abstract

We evaluated the effect of vagotomy on gastric acid secretion and the clinical course in 3 patients with Zollinger-Ellison syndrome. Basal acid hypersecretion was reduced by 49, 86, and 96%, and peak acid output in response to pentagastrin was reduced by 36, 39, and 71% in the 3 patients. In one patient, 300 mg cimetidine reduced basal acid secretion from 65 to 20 meq/hr before vagotomy; whereas after vagotomy basal acid secretion was reduced from 36 to 0.6 meq/hr by the same dose of cimetidine. One patient has required no antisecretory therapy for 14 yr, whereas 2 patients have also been treated with cimetidine with excellent results. We conclude that vagotomy facilitates control of acid secretion in Zollinger-Ellison syndrome, and we recommend vagotomy and cimetidine rather than total gastrectomy or cimetidine alone for the management of these patients. This combined surgical and medical approach should also allow discovery and removal of isolated tumors in about 10% of patients.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467924

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

Review 1.  An update on histamine receptors and the gastrointestinal tract.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1985-10       Impact factor: 3.199

2.  MEN I pancreas: a histological and immunohistochemical study.

Authors:  N W Thompson; R V Lloyd; R H Nishiyama; A I Vinik; W E Strodel; M D Allo; F E Eckhauser; G Talpos; T Mervak
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

3.  Primary peptic ulcerations of the jejunum associated with islet cell tumors. Twenty-five-year appraisal.

Authors:  R M Zollinger; E C Ellison; P J Fabri; J Johnson; J Sparks; L C Carey
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

4.  Cimetidine versus ranitidine for refractory Zollinger-Ellison syndrome.

Authors:  C J de Gara; T Gledhill; R H Hunt
Journal:  Can Med Assoc J       Date:  1984-03-01       Impact factor: 8.262

5.  The role of surgery in patients with Zollinger-Ellison syndrome (ZES) managed medically.

Authors:  M F Brennan; R T Jensen; R A Wesley; J L Doppman; D M McCarthy
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

6.  Low-risk thoracic vagotomy for anastomotic ulceration.

Authors:  L Lehr; R Pichlmayr
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

7.  Management of the patient presenting as an emergency with hypergastrinemia.

Authors:  N W Harris; D H Osborne; D C Carter
Journal:  World J Surg       Date:  1982-11       Impact factor: 3.352

8.  Serum gastrin response to secretin after vagotomy.

Authors:  M Feldman; J H Walsh; C T Richardson
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

9.  Removal of gastrinomas for control of Zollinger-Ellison syndrome.

Authors:  J W Harmon; J A Norton; M J Collin; A G Krudy; T H Shawker; J L Doppman; J d'Avis; R T Jensen
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

10.  The role of surgery in the Zollinger-Ellison syndrome.

Authors:  J C Thompson; B G Lewis; I Wiener; C M Townsend
Journal:  Ann Surg       Date:  1983-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.